Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 360 entries
View as:

Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System

Phase: N/A Priority: Normal
NCT ID: NCT00706095 Org: User:
Start: 02/29/08 End: 04/30/10 Due: 04/30/11

A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00292461 Org: User:
Start: 03/31/06 End: 09/30/09 Due: 09/30/10

An Open Label Dose Escalation Study Of E7080

Phase: N/A Priority: Normal
NCT ID: NCT00121719 Org: User:
Start: 07/01/05 End: 03/01/19 Due: 03/01/20

A Global, Postmarketing Observational Safety Study to Evaluate the Safety and Tolerability of Fycompa (Perampanel) as Add-on Therapy in Epilepsy Patients Aged Greater Than or Equal to 12 Years

Phase: N/A Priority: Normal
NCT ID: NCT02033902 Org: User:
Start: 06/06/14 End: 01/31/18 Due: 01/31/19

A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00943553 Org: User:
Start: 06/30/10 End: - Due: -

Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00828581 Org: User:
Start: 10/31/08 End: 12/31/08 Due: 12/31/09

A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02222324 Org: User:
Start: 08/31/14 End: 12/31/14 Due: 12/31/15

Trial of Decitabine in Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00260832 Org: User:
Start: 11/30/05 End: 12/31/10 Due: 12/31/11

GPI 15715 For Sedation in the Intensive Care Unit (ICU) Setting

Phase: N/A Priority: Normal
NCT ID: NCT00125398 Org: User:
Start: 07/31/05 End: 05/31/07 Due: 05/31/08

Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00658775 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00056576 Org: User:
Start: 02/28/02 End: 10/31/04 Due: 10/31/05

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT00334828 Org: User:
Start: 06/30/06 End: - Due: -

A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00477295 Org: User:
Start: 05/31/07 End: 01/31/11 Due: 01/31/12

Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00760084 Org: User:
Start: 07/31/05 End: 02/29/08 Due: 02/28/09

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Phase: N/A Priority: Normal
NCT ID: NCT02783729 Org: User:
Start: 05/31/16 End: 01/30/18 Due: 01/30/19

Pharmacokinetic Properties of Lorcaserin in the Fed and Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT00828724 Org: User:
Start: 11/30/08 End: 12/31/08 Due: 12/31/09

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00309179 Org: User:
Start: 09/24/07 End: 02/13/17 Due: 02/13/18

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

Phase: N/A Priority: Normal
NCT ID: NCT00165763 Org: User:
Start: 09/30/05 End: - Due: -

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy

Phase: N/A Priority: Normal
NCT ID: NCT00209534 Org: User:
Start: 01/31/03 End: 02/29/04 Due: 02/28/05

Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials

Phase: N/A Priority: Normal
NCT ID: NCT03477175 Org: User:
Start: 08/16/18 End: 12/21/23 Due: 12/21/24

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

Phase: N/A Priority: Normal
NCT ID: NCT02998775 Org: User:
Start: 12/02/16 End: 07/08/17 Due: 07/08/18

To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.

Phase: N/A Priority: Normal
NCT ID: NCT01011283 Org: User:
Start: 11/30/09 End: - Due: -

Rabeprazole Extended-Release 50 mg vs. Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00838526 Org: User:
Start: 08/31/08 End: 12/31/09 Due: 12/31/10

A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04763408 Org: User:
Start: 04/09/21 End: 12/13/23 Due: 12/13/24

E2007 Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00144690 Org: User:
Start: 03/31/05 End: 02/28/07 Due: 02/28/08